Walker et al., in a comprehensive genomic analysis performed on more than 800 patients, described and validated a peculiar MM population characterized by poor prognosis; the double-hit MM are defined as diseases harboring a bi-allelic inactivation of TP53 or an amplification of chromosome 1 involving the CSK1B gene together with ISS3. The gene discussed is TP53; the disease is Miyoshi myopathy.